Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01728753 · ClinicalTrials.gov registry record · Phase 1
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
A Phase 1 study, sponsored by MDVI.
- Completed
- Registry status
- Phase 1
- Development phase
- 550
- Enrollment target
NCT01728753 is a Phase 1 study that has completed, run by MDVI. The registered enrollment target is 550 participants.
The verdict
NCT01728753, a Phase 1 study, has completed, sponsored by MDVI.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 550 participants
- Enrollment target
Study Summary
This is safety and pharmacokinetics (PK) of favipiravir study in adults 18-80 years of age diagnosed with uncomplicated influenza.
Interventions
- DRUG Placebo
- DRUG Favipiravir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01728753
The ClinicalTrials.gov registry entry for NCT01728753 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MDVI, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01728753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01728753 about?
NCT01728753 is a clinical study titled "T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza". This is safety and pharmacokinetics (PK) of favipiravir study in adults 18-80 years of age diagnosed with uncomplicated influenza.
What is the current status of trial NCT01728753?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 550 participants. The study started on 2012-11. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01728753?
The interventions under investigation include: Placebo (DRUG), Favipiravir (DRUG).
Who is sponsoring clinical trial NCT01728753?
This trial is sponsored by MDVI, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.